Biogen Inc. is significantly expanding its West Coast presence by establishing an immunology hub in South San Francisco, building on its $1.5 billion acquisition of Human Immunology Biosciences (HI-Bio) last year. The Cambridge-based pharmaceutical company plans to nearly triple its footprint in the area, growing from approximately 9,000 square feet to 24,500 square feet at […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Duplexes and townhomes have climbed to about 16 percent of D.R. Horton’s...
ByThe RegistryNovember 7, 2026The submarket wrapped around Moscone Center and Yerba Buena Gardens was the...
ByThe RegistryNovember 7, 2026On the latest episode of CBRE's The Weekly Take podcast, Presidio Bay...
ByThe RegistryNovember 7, 2026The remote-first software company will leave its 83,000-square-foot space at Rincon Center...
ByThe RegistryNovember 7, 2026